← Leaderboards
Robert Munson Carey
University Of Virginia Charlottesville
$21,056,299
Attributed
$21,056,299
Total exposure
23
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$29,154,076 · 24
By mechanism
M01$11,624,028 · 14
R01$10,136,262 · 6
P01$5,765,021 · 3
T32$1,628,765 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Robin A Felder$10,596,071
- Helmy M Siragy$13,726,344
- Theodore E Mifflin$993,429
- Laureano D Asico$599,809
- Roberto Ariel Gomez$14,833,197
Others in their field
Top investigators on “Blood Pressure”
- David R. Weir · University Of Michigan At Ann Arbor$96,362,652
- Michael A Province · Washington University$60,417,406
- Leonardo Trasande · New York University School Of Medicine$55,277,738
- Rohit Varma · University Of Southern California$55,238,158
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$54,376,013
- Jiang He · Tulane University Of Louisiana$45,164,948
Research focus
Blood PressureKidneyHypertensionSodiumAngiotensin IiResponseExcretory FunctionReceptorMediatingCellsHuman SubjectNatriuresisRenin-Angiotensin SystemSalureticEssential HypertensionReceptor ExpressionSodium ChlorideFunctional DisorderDefectProximal Kidney TubulesLeadPlayClinical ResearchDopamine
Grant awards (69)
Renal AT2 Receptors in Hypertension$681,976
R01 · FY2022 · HL · contact PI
Renal AT2 Receptors in Hypertension$698,502
R01 · FY2021 · HL · contact PI
Renal sodium-bicarbonate co-transporter (SLC4A5) activity in human subjects with salt sensitivity of blood pressure: intrarenal mechanisms and role in blood pressure regulation$411,698
P01 · FY2020 · HL · contact PI
Renal AT2 Receptors in Hypertension$566,588
R01 · FY2019 · HL · contact PI
Renal sodium-bicarbonate co-transporter (SLC4A5) activity in human subjects with salt sensitivity of blood pressure: intrarenal mechanisms and role in blood pressure regulation$432,469
P01 · FY2019 · HL · contact PI
Renal AT2 Receptors in Hypertension$566,588
R01 · FY2018 · HL · contact PI
Renal sodium-bicarbonate co-transporter (SLC4A5) activity in human subjects with salt sensitivity of blood pressure: intrarenal mechanisms and role in blood pressure regulation$411,698
P01 · FY2018 · HL · contact PI
Renal AT2 Receptors in Hypertension$566,588
R01 · FY2017 · HL · contact PI
Renal sodium-bicarbonate co-transporter (SLC4A5) activity in human subjects with salt sensitivity of blood pressure: intrarenal mechanisms and role in blood pressure regulation$411,698
P01 · FY2017 · HL · contact PI
Renal AT2 Receptors in Hypertension$581,088
R01 · FY2016 · HL · contact PI
Renal sodium-bicarbonate co-transporter (SLC4A5) activity in human subjects with salt sensitivity of blood pressure: intrarenal mechanisms and role in blood pressure regulation$414,598
P01 · FY2016 · HL · contact PI
D1R and AT1R receptor interaction in human hypertension: clinical mechanisms$421,464
P01 · FY2014 · HL · contact PI
D1R and AT1R receptor interaction in human hypertension: clinical mechanisms$420,242
P01 · FY2013 · HL · contact PI
Renal AT2 Receptors in Hypertension$402,438
R01 · FY2013 · HL · contact PI
Research Training in Neuroendocrinology$212,952
T32 · FY2013 · DK · contact PI
Renal AT2 Receptors in Hypertension$425,810
R01 · FY2012 · HL · contact PI
D1R and AT1R receptor interaction in human hypertension: clinical mechanisms$393,877
P01 · FY2012 · HL · contact PI
Research Training in Neuroendocrinology$151,485
T32 · FY2012 · DK · contact PI
Renal AT2 Receptors in Hypertension$431,846
R01 · FY2011 · HL · contact PI
Research Training in Neuroendocrinology$116,758
T32 · FY2011 · DK · contact PI
Natriuretic mechanisms of AT2 receptors$452,098
R01 · FY2010 · HL · contact PI
Renal AT2 Receptors in Hypertension$448,838
R01 · FY2010 · HL · contact PI
D1R and AT1R receptor interaction in human hypertension: clinical mechanisms$430,032
P01 · FY2010 · HL · contact PI
Research Training in Neuroendocrinology$236,779
T32 · FY2010 · DK · contact PI
URINARY ANGIOTENSINOGEN EXCRETION IN NORMALS AND PATIENTS WITH TYPE II DM$105,576
M01 · FY2010 · RR · contact PI
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE$16,037
M01 · FY2010 · RR · contact PI
PRESSURE NATRIURESIS MEDIATED BY EXTRACELLULAR cGMP$446,944
R01 · FY2009 · HL · contact PI
Natriuretic mechanisms of AT2 receptors$444,814
R01 · FY2009 · HL · contact PI
D1R and AT1R receptor interaction in human hypertension: clinical mechanisms$435,368
P01 · FY2009 · HL · contact PI
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE$256,401
M01 · FY2009 · RR · contact PI
Research Training in Neuroendocrinology$191,063
T32 · FY2009 · DK · contact PI
CLINICAL TRIAL: EFFECT OF GENE VARIANTS ON DOPAMINE RECEPTOR NATRIURETIC RESPONS$89,692
M01 · FY2009 · RR · contact PI
URINARY ANGIOTENSINOGEN EXCRETION IN NORMALS AND PATIENTS WITH TYPE II DM$45,821
M01 · FY2009 · RR · contact PI
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE$487,753
M01 · FY2008 · RR · contact PI
PRESSURE NATRIURESIS MEDIATED BY EXTRACELLULAR cGMP$425,247
R01 · FY2008 · HL · contact PI
D1 and AT1 Receptor Interaction--Hypertension--clinical correlates$389,383
P01 · FY2008 · HL · contact PI
CLINICAL TRIAL: EFFECT OF GENE VARIANTS ON DOPAMINE RECEPTOR NATRIURETIC RESPONS$250,770
M01 · FY2008 · RR · contact PI
Research Training in Neuroendocrinology$157,401
T32 · FY2008 · DK · contact PI
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE$949,682
M01 · FY2007 · RR · contact PI
PRESSURE NATRIURESIS MEDIATED BY EXTRACELLULAR cGMP$421,287
R01 · FY2007 · HL · contact PI
D1 and AT1 Receptor Interaction--Hypertension--clinical correlates$387,398
P01 · FY2007 · HL · contact PI
Research Training in Neuroendocrinology$170,270
T32 · FY2007 · DK · contact PI
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE$598,911
M01 · FY2006 · RR · contact PI
PRESSURE NATRIURESIS MEDIATED BY EXTRACELLULAR cGMP$427,510
R01 · FY2006 · HL · contact PI
D1 and AT1 Receptor Interaction--Hypertension--clinical$276,337
P01 · FY2006 · HL · contact PI
Research Training in Neuroendocrinology$200,074
T32 · FY2006 · DK · contact PI
PRESSURE NATRIURESIS MEDIATED BY EXTRACELLULAR cGMP$427,824
R01 · FY2005 · HL
D1 and AT1 Receptor Interaction--Hypertension--clinical$268,286
P01 · FY2005 · HL
Research Training in Neuroendocrinology$191,983
T32 · FY2005 · DK
D1, AT1 RECEPTORS IN HUMAN HYPERTENSION: SODIUM SENSITIVITY OF BLOOD PRESSURE$48,054
M01 · FY2005 · RR
AT2 RECEPTORS IN BLOOD PRESSURE AND RENAL FUNCTION$296,000
R01 · FY2004 · HL
D1 and AT1 Receptor Interaction--Hypertension--clinical$260,473
P01 · FY2004 · HL
AT2 RECEPTORS IN BLOOD PRESSURE AND RENAL FUNCTION$296,000
R01 · FY2003 · HL
AT2 RECEPTORS IN BLOOD PRESSURE AND RENAL FUNCTION$296,000
R01 · FY2002 · HL
RENAL ANGIOTENSIN (AT2) RECEPTOR FUNCTION$48,533
M01 · FY2002 · RR
GENERAL CLINICAL RESEARCH CENTER$4,095,808
M01 · FY2001 · RR
AT2 RECEPTORS IN BLOOD PRESSURE AND RENAL FUNCTION$296,000
R01 · FY2001 · HL
AT2 RECEPTOR MECHANISMS IN ANG II DEPENDENT HYPERTENSION$271,250
R01 · FY2001 · HL
GCRC-CAP-STACEY M. ANDERSON-GILDERSLEEVE, M.D.$85,052
M01 · FY2001 · RR
RENAL ANGIOTENSIN (AT2) RECEPTOR FUNCTION$48,533
M01 · FY2001 · RR
GENERAL CLINICAL RESEARCH CENTER$3,856,880
M01 · FY2000 · RR
AT2 RECEPTOR MECHANISMS IN ANG II DEPENDENT HYPERTENSION$265,026
R01 · FY2000 · HL
INTERACTIONS OF THE RENAL DOPAMINERGIC AND RENIN ANGIOTENSIN SYSTEMS$248,088
M01 · FY2000 · RR
RENAL DOPAMINE RECEPTOR STIMULATION WITH FENOLDOPAM IN ESSENTIAL HYPERTENSION$248,088
M01 · FY2000 · RR
GCRC-CAP-SUSAN KIRK, M.D. (ADDITIONAL TIME)$60,037
M01 · FY2000 · RR
INTERACTIONS OF THE RENAL DOPAMINERGIC AND RENIN ANGIOTENSIN SYSTEMS$28,104
M01 · FY2000 · RR
RENAL DOPAMINE RECEPTOR STIMULATION WITH FENOLDOPAM IN ESSENTIAL HYPERTENSION$28,104
M01 · FY2000 · RR
RENAL ANGIOTENSIN (AT2) RECEPTOR FUNCTION$28,104
M01 · FY2000 · RR
RENAL ANGIOTENSIN (AT2) RECEPTOR FUNCTION$0
M01 · FY2000 · RR